Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Cellular Immunology
|
April 15, 1986
Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines
P J Reitnauer, L R Brown, J A Hank, et al.
Cellular Immunology
|
February 1, 1989
Selective lysis of target cells by interleukin-2-expanded peripheral blood mononuclear leukocyte clones
B P Chen, J A Hank, E E Kraus, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1988
Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions
P C Kohler, J A Hank, D Z Minkoff, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 1998
Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapy
C M Nicolet, J M Surfus, J A Hank, et al.
Journal of Biological Response Modifiers
|
October 1, 1988
Transient decrease in IL-2-responsive lymphocytes 24 hours after initiation of continuous IL-2 infusion in cancer patients
G Weil-Hillman, J A Hank, N S Rosenthal, et al.
The Journal of Clinical Investigation
|
June 1, 1983
HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro
P M Sondel, J A Hank, T Wendel, et al.
Journal of Supramolecular Structure
|
January 1, 1980
Long-term maintenance of "cloned" human PLT cells in TCGF with LCL cells as a feeder layer
J A Hank, H Inouye, L A Guy, et al.
Transplantation
|
September 1, 1989
Specific recognition of human leukemic cells by allogeneic T cell lines
J A Sosman, K R Oettel, J A Hank, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes
P M Sondel, J A Hank, P C Kohler, et al.
The Journal of Infectious Diseases
|
May 1, 1981
Influence of the virulence of Mycobacterium tuberculosis on protection induced by bacille Calmette-Guérin in guinea pigs
J A Hank, J K Chan, M L Edwards, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Cellular Immunology
|
April 15, 1986
Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines
P J Reitnauer, L R Brown, J A Hank, et al.
Cellular Immunology
|
February 1, 1989
Selective lysis of target cells by interleukin-2-expanded peripheral blood mononuclear leukocyte clones
B P Chen, J A Hank, E E Kraus, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1988
Clinical adoptive chemoimmunotherapy with allogeneic alloactivated HLA-haploidentical lymphocytes: controlled induction of graft-versus-host-reactions
P C Kohler, J A Hank, D Z Minkoff, et al.
Cancer Immunology, Immunotherapy : CII
|
October 2, 1998
Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapy
C M Nicolet, J M Surfus, J A Hank, et al.
Journal of Biological Response Modifiers
|
October 1, 1988
Transient decrease in IL-2-responsive lymphocytes 24 hours after initiation of continuous IL-2 infusion in cancer patients
G Weil-Hillman, J A Hank, N S Rosenthal, et al.
The Journal of Clinical Investigation
|
June 1, 1983
HLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro
P M Sondel, J A Hank, T Wendel, et al.
Journal of Supramolecular Structure
|
January 1, 1980
Long-term maintenance of "cloned" human PLT cells in TCGF with LCL cells as a feeder layer
J A Hank, H Inouye, L A Guy, et al.
Transplantation
|
September 1, 1989
Specific recognition of human leukemic cells by allogeneic T cell lines
J A Sosman, K R Oettel, J A Hank, et al.
Progress in Clinical and Biological Research
|
January 1, 1989
"Lymphokine activated killing" as treatment for human cancer: clinical extrapolations from laboratory studies with interleukin-2 expanded leukocytes
P M Sondel, J A Hank, P C Kohler, et al.
The Journal of Infectious Diseases
|
May 1, 1981
Influence of the virulence of Mycobacterium tuberculosis on protection induced by bacille Calmette-Guérin in guinea pigs
J A Hank, J K Chan, M L Edwards, et al.
Page
of 10